36
DAFTAR PUSTAKA
1. Indonesia KKR. Stop Kanker. Situasi Penyakit Kanker. 2015 Febuari: p. 7.
2. Cao SM, Simons MJ, Qian aCN. The Prevalence and Prevention of Nasopharyngeal Carcinoma in China. Chinese Journal of Cancer. 2011 january; 30(2).
3. American Cancer Society. [Online].; 2015 [cited 2015 January 15. Available from:
http://www.cancer.org/cancer/nasopharyngealcancer/detailedguide/nasophary ngeal-cancer-what-is-nasopharyngeal-cancer
4. International Agency of Research on Cancer. [Online].;2010 Available from:
http://www.iarc.fr/search.php?cx=009987501641899931167
5. Richard S. Snell MD. Clinical Anatomy For Medical Students. 6th ed. et.al HH, editor.: EGC; 2002.
6. Nasional KPK. Panduan Praktisi Klinis Karsinoma Nasofaring: Kementrian Kesehatan Republik Indonesia; 2008.
7. Control UfIC. World Health Organization. [Online].; 2014 [cited 2016 April 23.
8. Su O, Mao , Liang , Liu , al Je. American Cancer Society. [Online].; 2015 [cited 2016.
9. Indonesia FKU. Buku Ajar Ilmu Kesehatan. In Prof.Dr.Efiaty Arsyad Soepardi sTea, editor. Telinga Hidung Tenggorokan Kepala&Leher. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2007. p. 169.
10. Daniel T.T.Chua MBCB, Jonathan S.T.Sham MD, Damon T.k.Choy MBBS. Prognostic Impact of Hemoglobin Levels on Treatment Outcome in Patients with Nasopharyngeal Carcinoma Treated with Sequential Chemoradiotherapy or Radiotherapy Alone. American Cancer Society. 2004 June; 101(2).
11. su Z, Mao YP, OuYang PY, Tang J, Lan Xw, Xie FY. Leucopenia and treatment effiacy in advanced nasopharyngeal carcinoma. BioMedCentral Cancer. 2015.
37
12. Mehta A, Hoffbrand V. At a Glance Hematologi. 2nd ed. Safitri A, Astikawati R, editors.: copyright Erlangga; 2008.
13. Lichtman MAMD, Beutler EMD, Kipps TJMD,PD, et.al. Williams
Jr.Ligget WH, Forastiere AA. Chemotherapy for Head and Neck Cancer. In al CCWe, editor. Otolaryngology-Head and Neck Surgery.; 1999. p. 124-126.
Kentjono WA, Kemoterapi pada Tumor Ganas THT-Kepala Leher Pendidikan Kedokteran Berkelanjutan III Ilmu Penyakit Telinga Hidung Tenggorok-Kepala Leher, SMF Ilmu Penyakit THT FK Unair/ RSUD dr. Soetomo, Surabaya November 2002,108- 21
Suzuki RK, Hata M, Tateishi U, Taguchi T, Takano S, Minaswisawa MO, et al. Defenitive chemo-radiotherapy for squamous cell carcinoma of the pharynx:impact of baseline low hemoglobin level. The Japanese Society of Nuclear Medicine.2014 September.
HannaDams-Kozlowska , ElizaKwiatkowska-Borowczyk , Gryska K Lewandowska A, Marszalek A, Sebastian A, et al. Effects of Designer Hyper-Interleukin 11 (H11)on Hematopoiesisin Myelosuppressed Mice. The National Science Center, Poland. 2016 April.
MurayK R, Granner k D, Roadwell w V. Biokimia Harper. 27th ed. Wulandari N, Rendy L, Dwijayanthi L, Liena , Dany F, Rachman L, editors. Jakarta: EGC; 2009.
Sherwood L. Fisiologi Manusia Pendit B, Santoso B, editors. Jakarta: EGC; 2009.
38
23
24
25
26
Newman D. Kamus Kedokteran Dorland. 29th ed. Setiawan A, Bani A, Widjaja Aea, editors. Jakarta: EGC; 2002.
Woo JK, Hasselt CA, Nasopharyngeal Carcinoma, in : Scott-Brown’s Otorhinolaryngologi, Head And Neck Surgery, 7th edition, volume 2, Great Britain,2008 ; p.2445-70.
Ondrey FG, Wright SK, Neoplasma of the Nasopharynx, in ; Ballanger’s
Manual of Otorhinolaryngology Head and neck Surgery,Hamilton, Ontario,
2003; p.484-95.
Chan et al, Nasopharyngeal Carcinoma, in : Pathology and Genetics of Head and neck Tumours, WHO Classification of Tumours, Lyon, 2005,p.81-97.
23.
